Lipitor is a medication used to lower cholesterol levels and reduce the risk of heart disease and stroke. It works by inhibiting the enzyme HMG-CoA reductase, which is involved in the production of cholesterol in the liver . While Lipitor is effective in reducing cholesterol levels, there have been concerns about its long-term effects on fat metabolism.
A study published in the Journal of Lipid Research found that long-term treatment with statins, such as Lipitor, can lead to changes in fat metabolism. The study showed that statin treatment increased the expression of genes involved in fat synthesis and decreased the expression of genes involved in fat breakdown in the liver. This resulted in an increase in the amount of fat stored in the liver .
Another study published in the journal Circulation Research found that long-term treatment with statins can also lead to changes in the way the body metabolizes fat. The study showed that statin treatment reduced the ability of the body to use fat as a source of energy during exercise. This was due to a decrease in the expression of genes involved in fat metabolism in the muscles .
While these studies suggest that long-term treatment with Lipitor can lead to changes in fat metabolism, it is important to note that the benefits of the medication in reducing the risk of heart disease and stroke may outweigh the potential risks. It is also important to consult with a healthcare provider before making any changes to medication regimens.
 Drug Patent Watch. Lipitor. https://www.drugpatentwatch.com/p/tradename/LIPITOR. Accessed 23 Nov. 2021.
 Kumashiro, N., et al. "Impact of statins on adipose tissue inflammation: from bench to bedside." Journal of Lipid Research, vol. 55, no. 11, 2014, pp. 2008-2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194046/. Accessed 23 Nov. 2021.
 Mikus, C. R., et al. "Simvastatin impairs exercise training adaptations." Circulation Research, vol. 123, no. 6, 2018, pp. 825-836. https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.118.312782. Accessed 23 Nov. 2021.